XASXEMV
Market cap100mUSD
Dec 27, Last price
1.88AUD
1D
0.00%
1Q
-8.29%
IPO
452.94%
Name
EMvision Medical Devices Ltd
Chart & Performance
P/E
—
P/S
14.33
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
11.36%
Rev. gr., 5y
51.31%
Revenues
11m
+60.89%
Net income
-3m
L-29.48%
CFO
-6m
L
Earnings
Feb 26, 2025
Profile
EMvision Medical Devices Limited, a medical device company, engages in the research, development, and commercialization of imaging and diagnostic technology products. It develops a portable brain scanner for stroke diagnosis, monitoring, as well as other medical imaging needs. The company was incorporated in 2017 and is based in Macquarie Park, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | |
| Income | |||||||
Revenues | 11,219 60.89% | 6,973 59.92% | 4,360 156.66% | ||||
Cost of revenue | 12,834 | 10,928 | 10,467 | ||||
Unusual Expense (Income) | |||||||
NOPBT | (1,614) | (3,955) | (6,107) | ||||
NOPBT Margin | |||||||
Operating Taxes | 698 | (2,501) | (1,990) | ||||
Tax Rate | |||||||
NOPAT | (2,312) | (1,454) | (4,116) | ||||
Net income | (2,730) -29.48% | (3,871) -36.64% | (6,109) -27.26% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 15,248 | (6) | 1,258 | ||||
BB yield | -8.78% | 0.01% | -1.12% | ||||
| Debt | |||||||
Debt current | 1,070 | 2,728 | 197 | ||||
Long-term debt | 2,144 | 626 | 1,082 | ||||
Deferred revenue | |||||||
Other long-term liabilities | 72 | 53 | 31 | ||||
Net debt | (15,459) | (6,615) | (5,520) | ||||
| Cash flow | |||||||
Cash from operating activities | (5,992) | 834 | (3,782) | ||||
CAPEX | (115) | (187) | (191) | ||||
Cash from investing activities | (302) | (187) | (191) | ||||
Cash from financing activities | 15,001 | 2,523 | 1,083 | ||||
FCF | (2,882) | (1,299) | (4,756) | ||||
| Balance | |||||||
Cash | 18,672 | 9,969 | 6,799 | ||||
Long term investments | |||||||
Excess cash | 18,112 | 9,620 | 6,581 | ||||
Stockholders' equity | 18,516 | 5,115 | 7,081 | ||||
Invested Capital | 3,377 | 3,094 | 1,269 | ||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | 80,437 | 77,711 | 75,193 | ||||
Price | 2.16 84.62% | 1.17 -22.00% | 1.50 -50.17% | ||||
Market cap | 173,744 91.09% | 90,922 -19.39% | 112,789 -46.54% | ||||
EV | 158,285 | 84,307 | 107,269 | ||||
EBITDA | (1,614) | (3,613) | (5,863) | ||||
EV/EBITDA | |||||||
Interest | 116 | 35 | 18 | ||||
Interest/NOPBT | |||||||